TransUnion (TRU)
NYSEIndustrialsFinancial - Data & Stock ExchangesSnapshot 2026-11-04
$82.13+4.56%
Close 2026-11-04 · 1-day change
NYSEIndustrialsFinancial - Data & Stock ExchangesSnapshot 2026-11-04
Research Workspace
Put TRU beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Industrials is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Revenue growth from acquisitions: Revenue: $1.31B.
View ThesisRevenue growth is accelerating — up about 13% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 30% in its worst 12-month stretch.
View RiskTransUnion's high-single digit organic growth must keep compounding to justify the price. Revenue grew 12% year over year in the latest quarter. The company beat earnings estimates by 17.9% in that period. It trades at 17x earnings versus a 22x peer median. The price reflects less growth than our forecast. Revenue growth from acquisitions is under pressure. The thesis is on watch. Peer multiples imply a price about 4% above where it trades. This read is provisional.
Trailing returns as of 2026-11-04. TRU is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 22 analysts currently covering TRU (as of Nov 2026).
Based on 12 Wall Street analysts offering 12-month price targets for TRU in the last 4 months.
Continue this research
Compare TRU with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| TRU Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 13 valuation methods, at three horizons. As of 2026-11-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Research & Consulting Services — fair value, gap to price, and forward P/E.
Compare the value case
Put TRU next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Achieve high-single digit organic constant currency revenue growth
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $82.13
The last 12 months of price, then the range of analyst 12-month targets from today’s $82.13.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
8%-9% organic constant-currency growth meets the objective; planned buybacks support capital returns.
Advances: Drive innovation-led, scalable growth
New mortgage simulator API supports product innovation and scalable growth, though no adoption or financial impact is reported.
New rule change may impact competitive landscape.
Threatens: Drive innovation-led, scalable growth
Pricing strategy may hinder innovation-led growth.
CFO departure raises concerns about leadership stability.
CFO departure may disrupt financial strategy execution.
CFO departure may disrupt financial strategy execution.
FICO's decline may indicate competitive pressures on TRU.
